IRVINE, Calif.–(BUSINESS WIRE)–Jul. 21, 2016–
Masimo
(NASDAQ: MASI) announced today that a new study of patients undergoing
liver transplantation evaluated the relationship of PVI® to
right ventricular end-diastolic volume (RVEDVI) and concluded that PVI
provided a “reliable estimate of [cardiac] preload status and may be a
useful predictor of fluid responsiveness.”1 PVI measures the
dynamic changes in perfusion index that occur during one or more
complete respiratory cycles, using the Masimo pulse oximetry
plethsymographic waveform.

Because of hemodynamic instability during orthotopic liver
transplantati…

Más información: New Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness in Patients Undergoing Liver Transplantation